Skip to main content
. 2016 Nov 22;21(11):1574. doi: 10.3390/molecules21111574

Table 3.

Protective activity of 6f against RSB a.

Compound Treatment (μg/mL) Lesion Lengtha (mm) Protection Efficacy (%)
6f 200 5.1 68.9
100 5.5 66.5
validamycin A 200 4.3 73.8
100 6.4 61.0
blank control 16.4

a Values are the average of 20 replicates.